BOTHELL, WA– November 15, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Brian Noyes as the Vice President of Marketing for North America and South America.
“Brian is an excellent addition to Sonosite and we welcome him to the leadership team,” said Matthew Damron, Sonosite’s Global Chief Marketing Officer. “He is an accomplished leader with decades of experience in the medical device industry, a successful product launch track record, and a key factor in the growth of a $1 billion franchise at Johnson & Johnson. Brian is a very appealing candidate to further elevate our marketing execution to the next level with expertise that is essential as we prepare to unleash the most exciting products in our company’s history.”
“Sonosite is a company with tremendous growth opportunities and has an enviable position in the healthcare industry,” said Brian Noyes. “I’m joining the company at a very exciting time, and I look forward to capitalizing on the current marketing initiatives, driving product demand, and market expansion.”
Brian Noyes is an experienced leader in the healthcare industry and for the last 20 years, he worked at Ethicon Endo-Surgery (EES), a Johnson & Johnson Company, which is a leader in energy-based surgical devices. Holding positions of increasing responsibility, Mr. Noyes most recently served as the Global Product Director of the Energy Franchise where he was responsible for the development and marketing of a $1 billion franchise for laparoscopic products. In this role, Mr. Noyes was also responsible for launching products internationally and leading cross-functional teams. Previous to this position, he held managerial positions in sales and marketing. Prior to joining EES, Mr. Noyes worked at Camadon, Inc. in sales and marketing.
Mr. Noyes will report directly to Matthew Damron.
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.